Projects per year
Personal profile
Biography
Professor Ian Davis MB BS PhD FRACP FAChPM is a medical oncologist and is Professor of Medicine and Head of the Eastern Health Clinical School, Monash University and Eastern Health, in Melbourne, Australia. He is an NHMRC Practitioner Fellow. He holds honorary appointments with the Olivia Newton-John Cancer Research Institute (formerly Ludwig Institute for Cancer Research) and Austin Health, is an Associate Professor of the University of Melbourne, and Associate of the University of Sydney. His primary clinical interests are in urologic cancers, and his primary research interests are in cancer immunology and the biology of urologic cancers. Prof Davis is a member of the Medical & Scientific Committee and of the Standing Subcommittee on Research for the Cancer Council Victoria. He founded the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), is a member of COSA Council, and previously a COSA Board director. Prof Davis is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. Prof Davis has published over 250 papers with over 15,000 citations, attracted over $30M in grant funding, and been involved in over 200 clinical trials for which he was global or site Principal Investigator in over 120.
Education/Academic qualification
Cancer immunology, PhD, University of Melbourne
Award Date: 1 May 1997
Medicine, MB BS (First class honours), MONASH UNIVERSITY
Award Date: 7 Dec 1983
External positions
Professor of Medicine, Eastern Health
1 Jul 2012 → …Chair, Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
8 Oct 2008 → …Research area keywords
- Oncology
- Cancer Immunology
- Immunotherapy
- Genitourinary cancers
- VIC
- Bladder cancer
- Renal cell carcinoma
- Germ cell cancer
- Melanoma
- Clinical research
- Clinical trials
- Cancer biology
Network
Projects
-
Using smart technology to more effectively and efficiently monitor the quality of cancer care
Zalcberg, J., Evans, S., Bain, C., Aleti, A., Mac Manus, C., Brown, W., Sievert, W., Evans, P., Davis, I., Evans, M., Holland, J. & Brand, M.
Department of Health (Australia)
1/07/19 → 30/06/21
Project: Research
-
Out with Cancer: LGBTI experiences of cancer survivorship and care
Ussher, J. M., Perz, J., Hickey, M., Chambers, S. K., Dowsett, G. W., Robinson, K., Boydell, K., Davis, I., Parton, C., Anazodo, A. & McDonald, F.
5/02/18 → 31/12/21
Project: Research
-
Centre for Research Excellence in Prostate Cancer Survivorship (CRE-PCS)
Chambers, S. K., Newton, R. U., Scuffham, P., Baade, P., Galvao, D. A., Dunn, J., Smith, D., Wittert, G. A., Davis, I. & Gardiner, F.
1/11/16 → 31/10/21
Project: Research
-
Genomic & immunological predictors of response to intravesical therapy
Sengupta, S., Tran, B., Sluka, P., Anderson, P., Hayne, D. & Davis, I.
17/09/19 → 16/09/20
Project: Research
-
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)
10/01/17 → 9/01/18
Project: Research
Research output
-
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer
Sternberg, C. N., Saad, F., Graff, J. N., Peer, A., Vaishampayan, U. N., Leung, E., Rosenbaum, E., Gurney, H., Epstein, R. J., Davis, I. D., Wu, B., Trandafir, L., Wagner, V. J. & Hussain, M., Feb 2020, In : Annals of Oncology. 31, 2, p. 257-265 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open AccessFile3 Citations (Scopus) -
A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation
Ellis, R. J., Del Vecchio, S. J., Gallagher, K. M. J., Aliano, D. N., Barber, N., Bolton, D. M., Chew, E. T. S., Coombes, J. S., Coory, M. D., Davis, I. D., Donaldson, J. F., Francis, R. S., Giles, G. G., Gobe, G. C., Hawley, C. M., Johnson, D. W., Laird, A., Leung, S., Malki, M., Marco, D. J. T. & 8 others, , May 2020, In : Journal of the American Society of Nephrology : JASN. 31, 5, p. 1107-1117 11 p.Research output: Contribution to journal › Article › Research › peer-review
2 Citations (Scopus) -
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Galsky, M. D., Arija, J. Á. A., Bamias, A., Davis, I. D., De Santis, M., Kikuchi, E., Garcia-del-Muro, X., De Giorgi, U., Mencinger, M., Izumi, K., Panni, S., Gumus, M., Özgüroğlu, M., Kalebasty, A. R., Park, S. H., Alekseev, B., Schutz, F. A., Li, J. R., Ye, D., Vogelzang, N. J. & 7 others, , 16 May 2020, In : The Lancet. 395, 10236, p. 1547-1557 11 p.Research output: Contribution to journal › Article › Research › peer-review
61 Citations (Scopus) -
Compliance with follow-up for patients with stage 1 testicular germ cell tumour
Cheung, K. T., Dat, A., Wong, P., Dowling, C., Davis, I. D. & Sengupta, S., 2 Jul 2020, (Accepted/In press) In : ANZ Journal of Surgery. 3 p.Research output: Contribution to journal › Article › Research › peer-review
-
Effects of estrogen receptor signaling on prostate cancer carcinogenesis
Qu, L. G., Wardan, H., Davis, I. D., Pezaro, C. & Sluka, P., 1 Aug 2020, In : Translational Research. 222, p. 56-66 11 p.Research output: Contribution to journal › Review Article › Research › peer-review